Dexcom (DXCM) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.89% |
| Dec 31, 2025 | 14.71% |
| Sep 30, 2025 | 16.53% |
| Jun 30, 2025 | 19.38% |
| Mar 31, 2025 | 18.09% |
| Dec 31, 2024 | 16.22% |
| Sep 30, 2024 | 19.19% |
| Jun 30, 2024 | 24.86% |
| Mar 31, 2024 | 27.19% |
| Dec 31, 2023 | 24.13% |
| Sep 30, 2023 | 29.89% |
| Jun 30, 2023 | 28.89% |
| Mar 31, 2023 | 31.22% |
| Dec 31, 2022 | 28.67% |
| Sep 30, 2022 | 31.23% |
| Jun 30, 2022 | 30.78% |
| Mar 31, 2022 | 33.44% |
| Dec 31, 2021 | 32.28% |
| Sep 30, 2021 | 34.61% |
| Jun 30, 2021 | 37.30% |
| Mar 31, 2021 | 35.57% |
| Dec 31, 2020 | 34.34% |
| Sep 30, 2020 | 35.44% |
| Jun 30, 2020 | 33.90% |
| Mar 31, 2020 | 40.71% |
| Dec 31, 2019 | 39.10% |
| Sep 30, 2019 | 39.22% |
| Jun 30, 2019 | 38.93% |
| Mar 31, 2019 | 41.46% |
| Dec 31, 2018 | 45.56% |
| Sep 30, 2018 | 43.61% |
| Jun 30, 2018 | 47.64% |
| Mar 31, 2018 | 48.44% |
| Dec 31, 2017 | 54.39% |
| Sep 30, 2017 | 72.15% |
| Jun 30, 2017 | 60.02% |
| Mar 31, 2017 | 58.52% |
| Dec 31, 2016 | 61.26% |
| Sep 30, 2016 | 65.27% |
| Jun 30, 2016 | 48.35% |
| Mar 31, 2016 | 71.24% |
| Dec 31, 2015 | 67.15% |
| Sep 30, 2015 | 84.69% |
| Jun 30, 2015 | 70.96% |